The fixed dose combination of ROSUVASTATIN PLUS CLOPIDOGREL is indicated for the reduction of atherosclerotic events (Myocardial Infarction, stroke and vascular death) in patients with atherosclerosis documented by recent stroke, Myocardial Infarction or established peripheral arterial disease.
